HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyun Kyung Kim Selected Research

High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)

7/2022Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors.
10/2018Elevated extracellular trap formation and contact system activation in acute leukemia.
5/2017Contact system activation and high thrombin generation in hyperthyroidism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hyun Kyung Kim Research Topics

Disease

26Disseminated Intravascular Coagulation
07/2022 - 10/2002
16Thrombosis (Thrombus)
07/2022 - 10/2002
11Neoplasms (Cancer)
01/2019 - 01/2003
8Thrombophilia
01/2019 - 02/2009
7Infections
10/2018 - 04/2007
5Inflammation (Inflammations)
10/2018 - 01/2011
4Epilepsy (Aura)
10/2021 - 06/2010
4Thrombocytopenia (Thrombopenia)
11/2017 - 01/2011
4Fibrosis (Cirrhosis)
01/2017 - 09/2012
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2021 - 12/2009
3Multiple Myeloma
10/2018 - 06/2011
3Leukemia
10/2018 - 01/2007
3Liver Cirrhosis (Hepatic Cirrhosis)
04/2015 - 04/2004
3Liver Diseases (Liver Disease)
03/2014 - 10/2002
3Sepsis (Septicemia)
03/2014 - 10/2002
2COVID-19
05/2022 - 03/2022
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 08/2002
2Hematologic Neoplasms (Hematological Malignancy)
10/2018 - 11/2017
2Hemorrhage
11/2017 - 12/2016
2Lung Neoplasms (Lung Cancer)
12/2015 - 01/2013
2Disease Progression
01/2015 - 09/2013
2Hepatocellular Carcinoma (Hepatoma)
09/2013 - 01/2003
2Wounds and Injuries (Trauma)
09/2013 - 07/2008
1acquired Thrombotic thrombocytopenic purpura
11/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021
1Status Epilepticus (Complex Partial Status Epilepticus)
10/2021
1Diabetic Retinopathy (Retinopathy, Diabetic)
08/2021
1Weight Gain
01/2021
1Hot Flashes
01/2021
1Obesity
08/2020
1Drug Eruptions (Drug Eruption)
02/2020

Drug/Important Bio-Agent (IBA)

27Dacarbazine (DIC)FDA LinkGeneric
07/2022 - 10/2002
15ThrombinFDA Link
01/2019 - 02/2009
9FibrinIBA
12/2016 - 10/2002
7AnticoagulantsIBA
01/2016 - 12/2009
6DNA (Deoxyribonucleic Acid)IBA
05/2022 - 06/2015
6Histones (Histone)IBA
05/2022 - 06/2015
6fibrin fragment D (D-dimer)IBA
10/2018 - 01/2003
6Blood Coagulation Factors (Coagulation Factor)IBA
10/2018 - 04/2007
6Proteins (Proteins, Gene)FDA Link
11/2013 - 10/2002
4Leukocyte Elastase (Neutrophil Elastase)IBA
05/2022 - 03/2010
4AntibodiesIBA
11/2021 - 04/2004
4Heparin (Liquaemin)FDA LinkGeneric
01/2019 - 01/2011
4Fibrinogen (Factor I)FDA Link
10/2018 - 01/2007
3PrekallikreinIBA
07/2022 - 05/2017
3High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA
07/2022 - 05/2017
3Anticonvulsants (Antiepileptic Drugs)IBA
02/2020 - 06/2015
3Hemostatics (Antihemorrhagics)IBA
10/2018 - 01/2013
3Immunoglobulin G (IgG)IBA
05/2017 - 12/2009
3Thromboplastin (Tissue Factor)IBA
05/2017 - 02/2004
3ThrombomodulinIBA
09/2013 - 01/2011
3PolymersIBA
01/2004 - 10/2002
2Biomarkers (Surrogate Marker)IBA
05/2022 - 06/2010
2PhosphatidylserinesIBA
11/2021 - 03/2019
2Prothrombin (Factor II)IBA
11/2021 - 06/2013
2Antiphospholipid AntibodiesIBA
11/2021 - 12/2016
2LipidsIBA
10/2021 - 10/2018
2Insulin (Novolin)FDA Link
10/2021 - 02/2004
2LacosamideFDA Link
10/2021 - 02/2019
2Factor XII (Hageman Factor)IBA
08/2021 - 02/2016
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2019 - 11/2014
2AntithrombinsIBA
01/2019 - 03/2014
2EnzymesIBA
01/2019 - 01/2003
2BradykininIBA
10/2018 - 05/2017
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2018 - 11/2017
2Factor VII (Proconvertin)IBA
10/2018 - 05/2017
2Factor XIIa (Coagulation Factor XIIa)IBA
10/2018 - 05/2017
2C-Reactive ProteinIBA
03/2018 - 01/2007
2AutoantibodiesIBA
12/2016 - 12/2016
2plasma protein Z (protein Z)IBA
01/2016 - 04/2015
2Platelet Factor 4IBA
01/2015 - 01/2011
2Protein CIBA
05/2014 - 03/2014
2Messenger RNA (mRNA)IBA
09/2013 - 01/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2010 - 07/2003
2von Willebrand FactorIBA
05/2009 - 09/2008
1Oxygen (Dioxygen)IBA
03/2022
1ThrombospondinsIBA
11/2021
1DisintegrinsIBA
11/2021
1Glycoproteins (Glycoprotein)IBA
11/2021
1Metalloproteases (Metalloproteinases)IBA
11/2021
1thiamine triphosphorate (TTP)IBA
11/2021
1Betulinic AcidIBA
10/2021
1Factor VIIa (Activated Factor VII)IBA
07/2021
1Hormones (Hormone)IBA
01/2021
1AntioxidantsIBA
08/2020
1Carbamazepine (Tegretol)FDA LinkGeneric
02/2020
1Valproic Acid (Depakote)FDA LinkGeneric
02/2020
1Oxcarbazepine (Trileptal)FDA LinkGeneric
02/2020
1Lamotrigine (Lamictal)FDA LinkGeneric
02/2020
1Phenytoin (Dilantin)FDA LinkGeneric
02/2020
1Pharmaceutical PreparationsIBA
02/2020
1Phosphatidic Acids (Phosphatidic Acid)IBA
03/2019
1Sodium Channel BlockersIBA
02/2019
1polysialic acidIBA
01/2019

Therapy/Procedure

5Therapeutics
03/2022 - 11/2017
2Kidney Transplantation
10/2018 - 04/2016
2Stem Cell Transplantation
01/2018 - 06/2011
2Drug Therapy (Chemotherapy)
12/2015 - 08/2005
1Critical Care (Surgical Intensive Care)
03/2022
1Artificial Respiration (Mechanical Ventilation)
03/2022